BusinessMedical DevicesMedical InnovationsTechnology

The White House Office of Science and Technology Policy (OSTP) “Grand Challenge”

2 Mins read

Grand Challenges—the call to identify and resolve the biggest barriers to resolving global problems—have been around awhile. They started in 1900 with the German mathematician David Hilbert, who identified 23 major mathematics problems for his colleagues to solve (some were handled quickly, while quite a few have resisted resolution). The U.S.

Grand Challenges—the call to identify and resolve the biggest barriers to resolving global problems—have been around awhile. They started in 1900 with the German mathematician David Hilbert, who identified 23 major mathematics problems for his colleagues to solve (some were handled quickly, while quite a few have resisted resolution). The U.S. Department of Defense’s Advanced Research Projects Administration (DARPA) has regularly held Grand Challenges, which sparked innovation in unmanned vehicles and other technologies. And in the biomedical field, the 2003 Gates Foundation Grand Challenge posed 14 issues in global health; more than 1,000 proposals were submitted within three months of the foundation’s announcement, and the program is still going strong.

Today, there’s a new Grand Challenge and those of us in the life science community have an opportunity – if not an outright obligation – to respond. The White House Office of Science and Technology Policy (OSTP) wants to hear from us. It is the White House’s second grand challenge; the first was a sweeping quest for technological innovations. But this time, the OSTP wants input from the biomedical, biotech and research communities for its National Bioeconomy Blueprint. The White House asks a wide array of questions from “Identify one or more grand challenges for the bioeconomy…and suggest concrete steps that would need to be taken by the Federal government, companies, non-profit organizations, foundations and other stake holders to achieve this goal?” to possible new solutions for funding and venture capital to finding new ways of predicting protein function from genes.

OSTP is collecting responses until December 6. As an M&A advisory and specialty consulting firm committed to helping clients across the life sciences spectrum address complex challenges, we are interested in providing input to the OSTP – and we would love to take your thoughts into consideration.

What stands in the way of resolving our biggest biotechnology and medical issues? What do you think are our grand challenges?

Meet the challenge by sharing with us your proposals for how to meet the grand challenges! We’ll prepare a comprehensive summary of your ideas that we hope will serve as the basis for both responding to OSTP and for future blogs. Alas, the OSTP is not offering prizes or awards. But as history’s shown, grand challenges can lead to grand results.

Related posts
BusinessMarketing

5 Creative Ways to Advertise in the Healthcare Industry

4 Mins read
The healthcare industry is a dynamic one, with medical innovations, patient needs, financial obligations and changing regulations driving caregivers and administrators to…
BusinessFinance

How Invoice Factoring Can Help Medical Transcription Companies

6 Mins read
Medical transcription companies provide great services for hospitals, physicians, and clinics. Working in the healthcare industry can be very rewarding, but there…
Medical InnovationsSpecialtiesTechnology

Deciphering the Controversy of Adipose Derived Stem Cells in the Context of Healthcare

4 Mins read
As we enter a new era of medical advancements, several new techniques in medicine have been pioneered. You may have heard of…